QuVa Pharma awarded National Outsourced I.V. Admixture Services Agreement with Premier

Sugar Land, TX – December 5, 2018 – QuVa Pharma, Inc. a leading FDA registered 503B outsourcing provider of “ready-to-use” compounded I.V. products, announced today that it has been awarded a group purchasing agreement for Outsourced I.V Admixture Services with Premier. Effective January 1st 2019, this new agreement allows Premier members to take advantage of […]